Replacing what was lost: A novel cell therapy for type I diabetes mellitus

Research

View list of research

Researchers from The University of Tokyo developed a novel device for the safe and effective transplantation of human pancreatic beta-cells in type I diabetes mellitus (T1D). By constructing a millimeter-thick graft encapsulating beta-cells and transplanting it in diabetic mice, they were able to show that the device was removable for up to 1 year and without a significant foreign body response. This study demonstrates a novel option for cell therapy for T1D.

2021.04.02

Press Release

Replacing what was lost: A novel cell therapy for type I diabetes mellitus

Researchers from The University of Tokyo develop a novel device for the safe and effective transplantation of human induced pluripotent stem cell (iPSC)-derived pancreatic beta-cells in type I diabetes mellitus

Related Researchers

TAKEUCHI Shoji Project Professor

Biohybrid Systems

Department of Mechanical and Biofunctional Systems
LIMMS/CNRS-IIS (IRL2820) International Collaborative Research Center

Mechano-Informatics : Graduate School of Information Science and Technology
Multi-Disciplinary Sciences (Life Sciences) : Graduate School of Arts and Science
Advanced Interdisciplinary Studies : Graduate School of Engineering